Patents
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
12/2005
12/07/2005EP1527053B1 Process for preparing rizatriptan
12/07/2005EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors
12/07/2005CN1705657A Azole derivatives as antifungal agents
12/07/2005CN1705635A Inhibitors of histone deacetylase
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/01/2005WO2005113522A1 Azole carboxamide inhibitors of bacterial type iii protein secretion systems
12/01/2005US20050267185 1,2,4-triazole derivatives, compositions, process of making and methods of use
12/01/2005US20050267123 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
12/01/2005US20050266289 dialysis system or a two-phase reactor or a fuel cell containing a membrane comprised of a crosslinked copolymer; Exhibit extensive delocalization of negative charge; allow the preparation of macromolecules possessing dissociated and stable ionic functional groups
11/2005
11/30/2005EP1600442A1 Heteroarylcarbamoylbenzene derivative
11/30/2005EP1599174A2 Novel compounds
11/30/2005EP1511385B1 Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
11/30/2005EP1458381B1 Triazoles as oxytocin antagonists
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1229354C Acyl mercapto-triazolyl derivative and use thereof as microbiocides
11/29/2005US6969727 Obesity; osteoporosis
11/29/2005US6969715 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
11/29/2005US6969697 Substituted benzoylcyclohexenones
11/29/2005CA2420329C Sulphonylaminocarbonyltriazolinones
11/24/2005WO2005110971A1 Heteroaryl substituted cyclohexyl-1,4-diamine derivatives
11/24/2005US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/24/2005US20050261268 For therapy of allergic disorders, proliferative disorders, autoimmune disorders, conditions associated with organ transplant, inflammatory disorders, immunologically mediated disorders, viral diseases, or destructive bone disorders
11/24/2005DE102004021779A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments
11/24/2005CA2566917A1 Compounds containing a n-heteroaryl moiety linked to fused ring moieties for the inhibition of nad(p)h oxidases and platelet activation
11/24/2005CA2566212A1 Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives
11/23/2005EP1597260A1 Triazole compounds useful in therapy
11/23/2005EP1597249A1 Anthelmintic agents and insecticidal compositions
11/23/2005CN1699351A Substituted triazolone benzyl amine triazole antifungal compounds and method for preparing same
11/22/2005US6967251 Reagents for labeling biomolecules having aldehyde or ketone moieties
11/22/2005CA2068066C Herpesvirus particles and vaccine
11/17/2005WO2005108374A1 Insecticidal diazole and triazole derivatives
11/17/2005WO2005108373A1 Novel beta agonists, method for producing the same and their use as drugs
11/17/2005WO2005108347A2 Substituted enaminones, their derivatives and uses thereof
11/17/2005US20050256333 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
11/17/2005US20050256315 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
11/17/2005US20050256058 Propenoyl hydrazides
11/17/2005CA2564980A1 Novel beta agonists, method for producing the same and their use as drugs
11/16/2005EP1594850A2 Regiospecific process for the preparation of 4- 1- (4-cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile
11/16/2005EP1565447A4 1,2,4-triazole derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
11/16/2005CN1697650A Non-nucleoside reverse transcriptase inhibitors
11/16/2005CN1227229C Ethylene derivatives and pest controlling agents containing same
11/15/2005US6965004 Ethylene-styrene copolymers and phenol-triazole type complexes, catalysts, and processes for polymerizing
11/15/2005US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use
11/15/2005US6964939 Substituted thiene-3-yl-sulfonyl amino(thio)carbonyl-triazolin(thi)ones
11/15/2005CA2387517C Novel biaryl ether derivatives useful as monoamine reuptake inhibitors
11/10/2005WO2005105764A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005WO2005105762A1 Improved process for the preparation of high purity anastrozole
11/10/2005WO2005105746A1 Organometallic complex, luminous solid, organic el element and organic el display
11/10/2005WO2005082871A3 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
11/10/2005US20050250763 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
11/10/2005US20050250152 fluorescent derivatization reagents that label substances containing aldehydes, ketones, and similar functional groups, and their use in labeling glycoproteins and glycopeptides, nucleic acids and lipopolysaccharides, and other biomolecules
11/10/2005CA2565184A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/09/2005EP1593671A1 DPP-IV inhibitors
11/09/2005EP1592772A2 5ht7 antagonists and inverse agonists
11/09/2005EP1373227B1 Process for preparing fluconazole and its crystal modifications
11/09/2005EP0991709B1 Uv-stabilizers for siloxane systems
11/09/2005CN1226293C Method for preparing 2-(2-hydroxyphenyl)-2h-benzotriazole
11/09/2005CN1226250C Anthracene derivatives and organic electroluminescent device made by using the same
11/08/2005US6962936 Treating diseases such as cancer, inflammatory disorders, restenosis,
11/08/2005US6962931 Oral bioavailability of a CETP inhibitor
11/08/2005CA2155104C Heterocyclic-substituted alkyl amide acat inhibitors
11/03/2005WO2005103020A1 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
11/03/2005WO2005102989A1 Non-nucleoside reverse transcriptase inhibitors
11/03/2005WO2005054212A3 Electroluminescent device
11/03/2005WO2005006860A3 Azole derivatives and methods for making the same
11/03/2005WO2004099165A3 Heterocyclic compounds and hydro isomers thereof
11/03/2005US20050245592 2-Iminopyrrolidine derivatives
11/03/2005US20050245542 Pyridazine, pyrimidine and pyrazine ethyne compounds
11/03/2005US20050245526 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
11/03/2005DE102004018796A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments
11/03/2005CA2563615A1 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
11/03/2005CA2563180A1 Non-nucleoside reverse transcriptase inhibitors
11/02/2005EP1590344A2 Anti-cancer medicaments
11/02/2005EP1278719B1 Naphthamide neurokinin antagonists for use as medicaments
11/02/2005CN1692104A Benzotriazol-1-yl-amnioacetonitrile compounds and their use in the control of parasite disease
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
11/01/2005US6960604 Thyroid receptor ligands
11/01/2005US6960600 a triazole or amidazole compound containing oxy, hydroxy or aromatic rings; active on candidoses, cryptococcoses caused by Candida albicans; prevention of mycosic diseases in individuals with immunodeficiency.
10/2005
10/27/2005WO2005100352A1 Selected cgrp-antagonists, their preparation processes and their use as medicaments
10/27/2005WO2005100309A1 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
10/27/2005US20050240059 Process for the preparation of primary amines
10/27/2005US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
10/27/2005US20050239786 Triazole derivatives as tachykinin receptor antagonists
10/27/2005US20050239776 Tachykinin receptor antagonists
10/27/2005US20050235428 Use of metal complex compounds as oxidation catalysts
10/27/2005DE102004016845A1 Phenylthioessigsäure-Derivate und ihre Verwendung Phenylthioacetic acid derivatives and their use
10/27/2005CA2563386A1 Selected cgrp-antagonists, their preparation processes and their use as medicaments
10/27/2005CA2561554A1 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
10/26/2005EP1589001A1 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
10/26/2005EP1587795A1 N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as cgrp-antagonists for treating a headache
10/26/2005EP0835245B1 Substituted n-methylenethioureas as pesticides
10/26/2005CN1688555A Novel bicyclic inhibitors of hormone sensitive lipase
10/26/2005CN1688554A 1, 2, 4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
10/26/2005CN1224598C Naphthalene derivatives
10/25/2005CA2059882C Sulfonylureas
10/20/2005WO2005097784A1 Phenylthioacetic acid derivatives and use thereof
10/20/2005WO2005097759A1 Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/20/2005WO2005097758A1 Certain triazole-based compounds, compositions, and uses thereof
10/20/2005WO2005097112A2 Ion channel modulators
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 178